pI: 7.1209 |
Length (AA): 230 |
MW (Da): 24814 |
Paralog Number:
2
Signal peptide: Y | GPI Anchor: N | Predicted trans-membrane segments: 6
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 216 | 1z98 (A) | 34 | 265 | 24.00 | 0 | 0.34 | 1.33 | -2.39 |
3 | 223 | 1tm8 (A) | 7 | 231 | 25.00 | 0 | 0.68 | 1.39 | -1.88 |
8 | 214 | 1ldf (A) | 10 | 254 | 33.00 | 0 | 0.82 | 1.21 | -1.72 |
2 | 216 | 2f2b (A) | 1 | 245 | 29.00 | 0 | 0.85 | 1.16868 | -0.51 |
5 | 226 | 3d9s (A) | 10 | 242 | 27.00 | 0 | 0.84 | 1.21232 | -0.02 |
122 | 169 | 4l6v (L) | 90 | 136 | 47.00 | 0.75 | 0.21 | 0.572096 | 1 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_126615)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G19030 | aquaporin NIP1-1 |
Arabidopsis thaliana | AT4G01470 | 3 |
Arabidopsis thaliana | AT1G73190 | 1 |
Arabidopsis thaliana | AT4G18910 | 2 |
Arabidopsis thaliana | AT1G17810 | beta-tonoplast intrinsic protein |
Arabidopsis thaliana | AT3G16240 | aquaporin TIP2-1 |
Arabidopsis thaliana | AT2G34390 | 1 |
Arabidopsis thaliana | AT3G06100 | 1 |
Arabidopsis thaliana | AT2G25810 | 1 |
Arabidopsis thaliana | AT5G37820 | 2 |
Arabidopsis thaliana | AT1G31885 | 1 |
Arabidopsis thaliana | AT5G37810 | 1 |
Arabidopsis thaliana | AT2G16850 | 8 |
Brugia malayi | Bm1_03100 | Major intrinsic protein |
Brugia malayi | Bm1_03135 | Major intrinsic protein |
Brugia malayi | Bm1_03110 | Major intrinsic protein |
Brugia malayi | Bm1_03140 | Major intrinsic protein |
Brugia malayi | Bm1_57250 | Major intrinsic protein |
Caenorhabditis elegans | CELE_M02F4.8 | Protein AQP-7 |
Caenorhabditis elegans | CELE_C01G6.1 | Protein AQP-2, isoform B |
Caenorhabditis elegans | CELE_K02G10.7 | Protein AQP-8, isoform A |
Caenorhabditis elegans | CELE_Y69E1A.7 | Protein AQP-3 |
Dictyostelium discoideum | DDB_G0267378 | major intrinsic protein family protein |
Dictyostelium discoideum | DDB_G0280537 | aquaporin-like protein |
Drosophila melanogaster | Dmel_CG17664 | CG17664 gene product from transcript CG17664-RC |
Drosophila melanogaster | Dmel_CG9023 | CG9023 gene product from transcript CG9023-RG |
Drosophila melanogaster | Dmel_CG4019 | CG4019 gene product from transcript CG4019-RA |
Drosophila melanogaster | Dmel_CG17662 | CG17662 gene product from transcript CG17662-RB |
Escherichia coli | b0875 | aquaporin Z |
Escherichia coli | b3927 | glycerol facilitator |
Echinococcus granulosus | EgrG_001190800 | Aquaporin 9 AQP 9 Small solute channel 1 |
Echinococcus granulosus | EgrG_000153200 | Aquaporin 9 AQP 9 Small solute channel 1 |
Echinococcus multilocularis | EmuJ_000153200 | Glycosyltransferase, ALG10 |
Echinococcus multilocularis | EmuJ_001190800 | Aquaporin 9 (AQP 9) (Small solute channel 1) |
Homo sapiens | ENSG00000103569 | aquaporin 9 |
Homo sapiens | ENSG00000165272 | aquaporin 3 (Gill blood group) |
Homo sapiens | ENSG00000143595 | aquaporin 10 |
Homo sapiens | ENSG00000171885 | aquaporin 4 |
Homo sapiens | 362 | aquaporin 5 |
Homo sapiens | 101930168 | putative aquaporin-7-like protein 3-like |
Homo sapiens | ENSG00000165269 | aquaporin 7 |
Homo sapiens | ENSG00000259916 | putative aquaporin-7-like protein 3-like |
Leishmania braziliensis | LbrM.31.0020 | aquaglyceroporin |
Leishmania braziliensis | LbrM.32.2610 | aquaporin-like protein |
Leishmania braziliensis | LbrM.20.3460 | aquaporin 9, putative,major intrisic-like protein |
Leishmania donovani | LdBPK_310030.1 | Aquaglyceroporin 1 |
Leishmania donovani | LdBPK_343660.1 | aquaporin 9, putative |
Leishmania donovani | LdBPK_322500.1 | aquaporin-like protein |
Leishmania infantum | LinJ.34.3660 | aquaporin 9, putative,major intrisic-like protein |
Leishmania infantum | LinJ.32.2500 | aquaporin-like protein |
Leishmania infantum | LinJ.31.0030 | aquaglyceroporin |
Leishmania major | LmjF.31.0020 | aquaglyceroporin |
Leishmania major | LmjF.34.3850 | aquaporin 9, putative,major intrisic-like protein |
Leishmania major | LmjF.32.2380 | aquaporin-like protein |
Leishmania mexicana | LmxM.31.2380 | aquaporin-like protein |
Leishmania mexicana | LmxM.33.3850 | aquaporin 9, putative,major intrisic-like protein |
Leishmania mexicana | LmxM.30.0020 | aquaglyceroporin |
Loa Loa (eye worm) | LOAG_01613 | major intrinsic protein |
Loa Loa (eye worm) | LOAG_01620 | major intrinsic protein |
Loa Loa (eye worm) | LOAG_11786 | major intrinsic protein |
Mus musculus | ENSMUSG00000024411 | aquaporin 4 |
Mus musculus | ENSMUSG00000032204 | aquaporin 9 |
Mus musculus | ENSMUSG00000028435 | aquaporin 3 |
Mus musculus | ENSMUSG00000028427 | aquaporin 7 |
Mus musculus | ENSMUSG00000044217 | aquaporin 5 |
Oryza sativa | 4324277 | Os01g0232100 |
Oryza sativa | 4324303 | Os01g0975900 |
Oryza sativa | 4340941 | Os06g0336200 |
Oryza sativa | 4328814 | Os02g0232900 |
Oryza sativa | 4338163 | Os05g0231700 |
Oryza sativa | 4348981 | Os10g0492600 |
Oryza sativa | 4324276 | Os01g0232000 |
Oryza sativa | 4327074 | Os01g0202800 |
Onchocerca volvulus | OVOC11208 |
|
Onchocerca volvulus | OVOC11198 |
|
Onchocerca volvulus | OVOC11207 |
|
Plasmodium berghei | PBANKA_0915600 | aquaglyceroporin |
Plasmodium falciparum | PF3D7_1132800 | aquaglyceroporin |
Plasmodium knowlesi | PKNH_0931000 | aquaglyceroporin, putative |
Plasmodium vivax | PVX_092245 | aquaglyceroporin, putative |
Plasmodium yoelii | PY05950 | aquaglyceroporin |
Saccharomyces cerevisiae | YLL043W | Fps1p |
Saccharomyces cerevisiae | YFL054C | hypothetical protein |
Schistosoma japonicum | Sjp_0218290 | ko:K09876 aquaporin-3, putative |
Schistosoma japonicum | Sjp_0055350 | Aquaporin-9, putative |
Schistosoma japonicum | Sjp_0112230 | IPR000425,Major intrinsic protein,domain-containing |
Schistosoma japonicum | Sjp_0209930 | ko:K09877 aquaporin-9, putative |
Schistosoma japonicum | Sjp_0055360 | Aquaporin-9, putative |
Schistosoma mansoni | Smp_005720 | aquaporin-3 |
Schistosoma mansoni | Smp_005740 | aquaporin-3 |
Schmidtea mediterranea | mk4.003793.01 | |
Schmidtea mediterranea | mk4.014833.01 | |
Schmidtea mediterranea | mk4.002202.00 | |
Trypanosoma brucei gambiense | Tbg972.10.16540 | aquaglyceroporin (small solute channel), putative |
Trypanosoma brucei gambiense | Tbg972.6.1170 | aquaporin 3, putative |
Trypanosoma brucei | Tb927.10.14160 | Aquaglyceroporin 3 |
Trypanosoma brucei | Tb927.6.1520 | Aquaglyceroporin 1 |
Trypanosoma congolense | TcIL3000_10_12040 | aquaporin 3, putative |
Trypanosoma cruzi | TcCLB.504159.50 | aquaporin-like protein, putative |
Trypanosoma cruzi | TcCLB.508257.140 | Aquaporin 2 |
Trypanosoma cruzi | TcCLB.506821.170 | aquaporin-like protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.14160 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.14160 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.14160 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.14160 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.6.1520 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.6.1520 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.6.1520 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.6.1520 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0875 | Escherichia coli | non-essential | goodall |
b3927 | Escherichia coli | non-essential | goodall |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.